Talking about what others are afraid to say
GLP-1 drugs like Ozempic®, Wegovy®, Zepbound®, and Mounjaro® are revolutionizing the treatment of obesity. Study results showing typical weight loss between 15% and over 20% have generated unprecedented excitement among …
The GLP-1 Revolution Has a Retention Problem: What Social Media Is Revealing About the Hidden Challenge Read More
A clickstream is the digital trail a visitor leaves as they navigate your website. It shows where they entered, what content they consumed, where they hesitated, which resources they downloaded, …
Why Unlocking Patient Insights with Clickstream Analysis Is Essential Read More
GLP-1 drugs have become one of the biggest medical stories of the decade. Originally developed to treat type 2 diabetes, medications such as Ozempic, Wegovy, and Mounjaro are now being …
Can Weight Loss from GLP-1 Drugs Reduce Cancer Threat? Read More
Every time a new observational data point appears, the reaction is the same: Instant celebration. Instant amplification. Zero skepticism. Doctors should be the guardrails in moments like this. Instead, many …
The GLP-1 Hype Train Is Out of Control, and Physicians Are Shoveling the Coal Read More
Tangle provides a free newsletter on news and healthcare. The author’s piece was spot on, and I urge all of you to share it within our industry.
The HHS Cuts: They Will Make American Healthcare Worse Read More